Exhibit 99.1 Press Release dated March 23, 2023 Contact:Trinity Biotech plc Lytham Partners, LLC John Gillard Joe Diaz (353)-1-2769800 (1)-602-889-9700 E-mail: investorrelations@trinitybiotech.com Trinity Biotech Announces Fourth Quarter and Fiscal Year 2022 Financial Results DUBLIN, Ireland (March 23, 2023)…. Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended Dec ...

Trinity Biotech plc (NASDAQ:TRIB) Q4 2022 Earnings Conference Call March 23, 2023 10:00 AM ET Company Participants Joe Diaz - Lytham Partners, Investor Relations Aris Kekedjian - Chief Executive Officer John Gillard - Chief Financial Officer Conference Call Participants Jim Sidoti - Sidoti & Company Paul Nouri - Noble Equity Operator Good morning and welcome to the Trinity Biotech Fourth Quarter 2022 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] Aft ...